CD8A and neoplasm: In contrast, CD20+, CD4+, CD25+, FOXP3+, CD163+, T-bet+ and GATA3+ cell density as well as CD4/CD8, CD163/68 and GATA3/T-bet ratio did not differ significantly between the different tumor stages, Figure 4.